Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 422

1.

Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2.

Martínez-Torres S, Cutando L, Pastor A, Kato A, Sakimura K, de la Torre R, Valjent E, Maldonado R, Kano M, Ozaita A.

Brain Behav Immun. 2019 Jun 25. pii: S0889-1591(19)30344-7. doi: 10.1016/j.bbi.2019.06.036. [Epub ahead of print]

PMID:
31251974
2.

Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management.

Xicota L, Rodríguez J, Langohr K, Fitó M, Dierssen M, de la Torre R; TESDAD study group.

Clin Nutr. 2019 Jun 8. pii: S0261-5614(19)30255-9. doi: 10.1016/j.clnu.2019.05.028. [Epub ahead of print]

PMID:
31229326
3.

Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system.

Martín-Sánchez A, Warnault V, Montagud-Romero S, Pastor A, Mondragón N, De La Torre R, Valverde O.

Pharmacol Biochem Behav. 2019 Aug;183:22-31. doi: 10.1016/j.pbb.2019.06.007. Epub 2019 Jun 17.

PMID:
31220547
4.

Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains.

Di Rienzo M, Antonioli M, Fusco C, Liu Y, Mari M, Orhon I, Refolo G, Germani F, Corazzari M, Romagnoli A, Ciccosanti F, Mandriani B, Pellico MT, De La Torre R, Ding H, Dentice M, Neri M, Ferlini A, Reggiori F, Kulesz-Martin M, Piacentini M, Merla G, Fimia GM.

Sci Adv. 2019 May 8;5(5):eaau8857. doi: 10.1126/sciadv.aau8857. eCollection 2019 May.

5.

Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.

Mensen VT, Vreeker A, Nordgren J, Atkinson A, de la Torre R, Farré M, Ramaekers JG, Brunt TM.

Psychopharmacology (Berl). 2019 Apr 9. doi: 10.1007/s00213-019-05238-8. [Epub ahead of print]

PMID:
30968175
6.

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.

de la Torre R, de Sola S, Farré M, Xicota L, Cuenca-Royo A, Rodriguez J, León A, Langohr K, Gomis-González M, Hernandez G, Esteba S, Del Hoyo L, Sánchez-Gutiérrez J, Cortés MJ, Ozaita A, Espadaler JM, Novell R, Martínez-Leal R, Milá M, Dierssen M; TESXF Study Group.

Clin Nutr. 2019 Mar 25. pii: S0261-5614(19)30082-2. doi: 10.1016/j.clnu.2019.02.028. [Epub ahead of print]

PMID:
30962103
7.

Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers.

Martínez-Riera R, Pérez-Mañá C, Papaseit E, Fonseca F, de la Torre R, Pizarro N, Torrens M, Farré M.

Front Pharmacol. 2019 Feb 27;10:131. doi: 10.3389/fphar.2019.00131. eCollection 2019.

8.

Effects of Virgin Olive Oils Differing in Their Bioactive Compound Contents on Biomarkers of Oxidative Stress and Inflammation in Healthy Adults: A Randomized Double-Blind Controlled Trial.

Sanchez-Rodriguez E, Biel-Glesson S, Fernandez-Navarro JR, Calleja MA, Espejo-Calvo JA, Gil-Extremera B, de la Torre R, Fito M, Covas MI, Vilchez P, Alche JD, Martinez de Victoria E, Gil A, Mesa MD.

Nutrients. 2019 Mar 6;11(3). pii: E561. doi: 10.3390/nu11030561.

9.

Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants.

Romero-Sanchiz P, Nogueira-Arjona R, Pastor A, Araos P, Serrano A, Boronat A, Garcia-Marchena N, Mayoral F, Bordallo A, Alen F, Suárez J, de la Torre R, Pavón FJ, Rodríguez de Fonseca F.

Neuropharmacology. 2019 May 1;149:212-220. doi: 10.1016/j.neuropharm.2019.02.026. Epub 2019 Feb 26.

PMID:
30822499
10.

Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic Variation.

Olesti E, Farré M, Carbó ML, Papaseit E, Perez-Mañá C, Torrens M, Yubero-Lahoz S, Pujadas M, Pozo ÓJ, de la Torre R.

Clin Pharmacol Ther. 2019 Feb 27. doi: 10.1002/cpt.1417. [Epub ahead of print]

PMID:
30815856
11.

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.

Navarro-Romero A, Vázquez-Oliver A, Gomis-González M, Garzón-Montesinos C, Falcón-Moya R, Pastor A, Martín-García E, Pizarro N, Busquets-Garcia A, Revest JM, Piazza PV, Bosch F, Dierssen M, de la Torre R, Rodríguez-Moreno A, Maldonado R, Ozaita A.

Neurobiol Dis. 2019 May;125:92-106. doi: 10.1016/j.nbd.2019.01.014. Epub 2019 Jan 25.

PMID:
30685352
12.

Increased Consumption of Virgin Olive Oil, Nuts, Legumes, Whole Grains, and Fish Promotes HDL Functions in Humans.

Hernáez Á, Sanllorente A, Castañer O, Martínez-González MÁ, Ros E, Pintó X, Estruch R, Salas-Salvadó J, Corella D, Alonso-Gómez ÁM, Serra-Majem L, Fiol M, Lapetra J, Gómez-Gracia E, de la Torre R, Lamuela-Raventós RM, Fitó M.

Mol Nutr Food Res. 2019 Mar;63(6):e1800847. doi: 10.1002/mnfr.201800847. Epub 2019 Jan 15.

PMID:
30628167
13.

Metabolomics predicts the pharmacological profile of new psychoactive substances.

Olesti E, De Toma I, Ramaekers JG, Brunt TM, Carbó ML, Fernández-Avilés C, Robledo P, Farré M, Dierssen M, Pozo ÓJ, de la Torre R.

J Psychopharmacol. 2019 Mar;33(3):347-354. doi: 10.1177/0269881118812103. Epub 2018 Nov 19.

PMID:
30451567
14.

Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study.

Mallorquí-Bagué N, Lozano-Madrid M, Toledo E, Corella D, Salas-Salvadó J, Cuenca-Royo A, Vioque J, Romaguera D, Martínez JA, Wärnberg J, López-Miranda J, Estruch R, Bueno-Cavanillas A, Alonso-Gómez Á, Tur JA, Tinahones FJ, Serra-Majem L, Martín V, Lapetra J, Vázquez C, Pintó X, Vidal J, Daimiel L, Gaforio JJ, Matía P, Ros E, Granero R, Buil-Cosiales P, Barragán R, Bulló M, Castañer O, García-de-la-Hera M, Yáñez AM, Abete I, García-Ríos A, Ruiz-Canela M, Díaz-López A, Jiménez-Murcia S, Martínez-González MA, De la Torre R, Fernández-Aranda F.

Sci Rep. 2018 Oct 31;8(1):16128. doi: 10.1038/s41598-018-33843-8.

15.

Mechanisms of Connexin-Related Lymphedema.

Castorena-Gonzalez JA, Zawieja SD, Li M, Srinivasan RS, Simon AM, de Wit C, de la Torre R, Martinez-Lemus LA, Hennig GW, Davis MJ.

Circ Res. 2018 Sep 28;123(8):964-985. doi: 10.1161/CIRCRESAHA.117.312576.

PMID:
30355030
16.

Quantification of endogenous neurotransmitters and related compounds by liquid chromatography coupled to tandem mass spectrometry.

Olesti E, Rodríguez-Morató J, Gomez-Gomez A, Ramaekers JG, de la Torre R, Pozo OJ.

Talanta. 2019 Jan 15;192:93-102. doi: 10.1016/j.talanta.2018.09.034. Epub 2018 Sep 12.

PMID:
30348434
17.

Cranberries attenuate animal-based diet-induced changes in microbiota composition and functionality: a randomized crossover controlled feeding trial.

Rodríguez-Morató J, Matthan NR, Liu J, de la Torre R, Chen CO.

J Nutr Biochem. 2018 Dec;62:76-86. doi: 10.1016/j.jnutbio.2018.08.019. Epub 2018 Sep 8.

PMID:
30269035
18.

Wine and Olive Oil Phenolic Compounds Interaction in Humans.

Boronat A, Martínez-Huélamo M, Cobos A, de la Torre R.

Diseases. 2018 Sep 1;6(3). pii: E76. doi: 10.3390/diseases6030076.

19.

PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models.

Alen F, Decara J, Brunori G, You ZB, Bühler KM, López-Moreno JA, Cippitelli A, Pavon FJ, Suárez J, Gardner EL, de la Torre R, Ciccocioppo R, Serrano A, Rodríguez de Fonseca F.

Biochem Pharmacol. 2018 Nov;157:235-243. doi: 10.1016/j.bcp.2018.09.008. Epub 2018 Sep 6.

PMID:
30195735
20.

Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.

Ramon-Duaso C, Gener T, Consegal M, Fernández-Avilés C, Gallego JJ, Castarlenas L, Swanson MS, de la Torre R, Maldonado R, Puig MV, Robledo P.

Cereb Cortex. 2019 Jul 5;29(7):2978-2997. doi: 10.1093/cercor/bhy164.

PMID:
30060068

Supplemental Content

Loading ...
Support Center